144 related articles for article (PubMed ID: 34851501)
1. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
[TBL] [Abstract][Full Text] [Related]
4. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
[TBL] [Abstract][Full Text] [Related]
5. Test-retest repeatability of quantitative bone SPECT/CT.
Yamane T; Fukushima K; Shirotake S; Nishimoto K; Okabe T; Oyama M; Seto A; Kuji I
Ann Nucl Med; 2021 Mar; 35(3):338-346. PubMed ID: 33400148
[TBL] [Abstract][Full Text] [Related]
6. Quantitative bone SPECT/CT applications for primary bone neoplasms.
Kitajima K; Futani H; Komoto H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
Hell J Nucl Med; 2021; 24(1):36-44. PubMed ID: 33866337
[TBL] [Abstract][Full Text] [Related]
7. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
Toshima H; Ogura I
Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
[TBL] [Abstract][Full Text] [Related]
8. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
[TBL] [Abstract][Full Text] [Related]
9. Quantitative [
Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
Motegi K; Matsutomo N; Yamamoto T; Koizumi M
Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
[TBL] [Abstract][Full Text] [Related]
11. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
12. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
Tezuka Y; Ogura I
Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
An YS; Park DY; Min BH; Lee SJ; Yoon JK
BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions in Diagnosing Medication-related Osteonecrosis of the Jaw.
Beck MT; Rugel G; Reinfelder J; Kuwert T; Ritt P; Kreissel S; Schlittenbauer T
Nuklearmedizin; 2021 Dec; 60(6):403-410. PubMed ID: 34380154
[TBL] [Abstract][Full Text] [Related]
15. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
Ogawa R; Ogura I
Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
[TBL] [Abstract][Full Text] [Related]
16. Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.
Kitajima K; Futani H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
Hell J Nucl Med; 2020; 23(2):133-137. PubMed ID: 32716404
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardised uptake value.
Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
Clin Radiol; 2020 Jan; 75(1):46-50. PubMed ID: 31699430
[TBL] [Abstract][Full Text] [Related]
18. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
19. Comparison of standardized uptake values between
Arvola S; Jambor I; Kuisma A; Kemppainen J; Kajander S; Seppänen M; Noponen T
EJNMMI Res; 2019 Jan; 9(1):6. PubMed ID: 30680469
[TBL] [Abstract][Full Text] [Related]
20. Standardized uptake values of
Qi N; Meng Q; You Z; Chen H; Shou Y; Zhao J
BMC Med Imaging; 2021 Feb; 21(1):39. PubMed ID: 33639883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
